Cargando…

Poster: AML-108: Exogenous Mitochondrial Transfer and Endogenous Mitochondrial Fission Facilitate Resistance to OxPhos Inhibition in AML

Detalles Bibliográficos
Autores principales:	Tabe, Yoko, Saito, Kaori, Konopleva, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760201/ http://dx.doi.org/10.1016/S2152-2650(21)01321-5

Ejemplares similares

Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition
por: Saito, Kaori, et al.
Publicado: (2021)

OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases
por: Sturm, Gabriel, et al.
Publicado: (2023)

Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML
por: Tabe, Yoko, et al.
Publicado: (2020)

Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment
por: Tabe, Yoko, et al.
Publicado: (2023)

Mutations in TIMM50 compromise cell survival in OxPhos‐dependent metabolic conditions
por: Reyes, Aurelio, et al.
Publicado: (2018)

Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells
por: Vangapandu, Hima V., et al.
Publicado: (2018)

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis
por: Hurrish, Katie H., et al.
Publicado: (2023)

Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine
por: Tabe, Yoko, et al.
Publicado: (2018)

Bone marrow microenvironment drives AML cell OXPHOS addiction and AMPK inhibition to resist chemotherapy
por: You, Ruolan, et al.
Publicado: (2021)

TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment
por: Tabe, Yoko, et al.
Publicado: (2013)

Nicotinamide riboside regulates inflammation and mitochondrial markers in AML12 hepatocytes
por: Lee, Hee Jae, et al.
Publicado: (2019)

Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies
por: Wozniaki, Natalia, et al.
Publicado: (2021)

P521: FINDINGS FROM AN ANALYSIS OF PATIENTS WITH MONOCYTIC AND MONOCYTIC-LIKE ACUTE MYELOID LEUKEMIA (AML), INCLUDING AML-M4 AND AML-M5, TREATED WITH VENETOCLAX (VEN) PLUS AZACITIDINE (AZA)
por: Konopleva, Marina, et al.
Publicado: (2023)

Multi-omics reveals mitochondrial metabolism proteins susceptible for drug discovery in AML
por: Caplan, Mika, et al.
Publicado: (2022)

Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively
por: Dal Bello, Reinaldo, et al.
Publicado: (2022)

Parallel Structural Evolution of Mitochondrial Ribosomes and OXPHOS Complexes
por: van der Sluis, Eli O., et al.
Publicado: (2015)

Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers
por: Chen, Chia-Lin, et al.
Publicado: (2021)

Prediction of competing endogenous RNA coexpression network as prognostic markers in AML
por: Wang, Jun-Dan, et al.
Publicado: (2019)

Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML
por: Yamatani, Kotoko, et al.
Publicado: (2022)

AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
por: Gardini, Alessandro, et al.
Publicado: (2008)

The role of the proteasome in AML
por: Csizmar, C M, et al.
Publicado: (2016)

Maintenance Therapy in AML
por: Reville, Patrick K., et al.
Publicado: (2021)

Camalexin Induces Apoptosis via the ROS-ER Stress-Mitochondrial Apoptosis Pathway in AML Cells
por: Yang, Yang, et al.
Publicado: (2018)

SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation
por: Ma, Jiao, et al.
Publicado: (2019)

CALCRL Gene is a Suitable Prognostic Factor in AML/ETO(+) AML Patients
por: Wang, Rongrong, et al.
Publicado: (2022)

Poster 108: The Deep Region of the Supraspinatus Is Architecturally Distinct
por: Hyman, Sydnee, et al.
Publicado: (2023)

MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells
por: Zeng, Zhihong, et al.
Publicado: (2016)

A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity
por: Yeo, Janet H. C., et al.
Publicado: (2015)

Transcriptomic signals of mitochondrial dysfunction and OXPHOS dynamics in fast-growth chicken
por: Hubert, Shawna, et al.
Publicado: (2022)

Editorial: Mitochondrial OXPHOS System: Emerging Concepts and Technologies and Role in Disease
por: Fernández-Vizarra, Erika, et al.
Publicado: (2022)

A Case of Untreated Myeloid Sarcoma of the Pancreas Head Region: Diagnostic Process of AML Subtyping in an Autoptic Case
por: Fukumura, Yuki, et al.
Publicado: (2021)

The Challenge of AML in Older Patients
por: Burnett, Alan K
Publicado: (2013)

Targeting glutamine uptake in AML
por: Jacque, Nathalie, et al.
Publicado: (2014)

AML treatment in older adults
por: Sehgal, Alison, et al.
Publicado: (2015)

Impact of CNA on AML prognosis
por: Gonzales, Fanny, et al.
Publicado: (2017)

Treatments for children and adolescents with AML
por: Kim, Hyery
Publicado: (2020)

Emerging agents and regimens for AML
por: Liu, Hongtao
Publicado: (2021)

Von AML bis Zytokinfreisetzung
por: Klein, Friederike
Publicado: (2022)

Inherited predisposition to MDS/AML
por: Rio Machin, Ana, et al.
Publicado: (2018)

CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation
por: Federzoni, Elena A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1umlnoqgash2k8o1vql66r21hj